SilverCrest Metals
SILV
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
Cars.com
CARS
Halozyme Therapeutics
HALO
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 19.16%99.33M | 18.21%107.05M | 24.41%117.44M | -28.52%383.83M | -9.02%115.52M | -38.69%83.36M | -34.27%90.56M | -30.71%94.39M | -1.86%536.93M | -30.72%126.97M |
Operating revenue | 19.16%99.33M | 18.21%107.05M | 24.41%117.44M | -28.52%383.83M | -9.02%115.52M | -38.69%83.36M | -34.27%90.56M | -30.71%94.39M | -1.86%536.93M | -30.72%126.97M |
Cost of revenue | -9.08%70.97M | 10.91%76.8M | 2.98%83.87M | -7.34%315.66M | -1.11%86.92M | -7.21%78.05M | -15.02%69.25M | -6.58%81.44M | 6.17%340.68M | 0.04%87.9M |
Gross profit | 434.50%28.37M | 41.94%30.25M | 159.13%33.57M | -65.27%68.16M | -26.83%28.59M | -89.76%5.31M | -62.13%21.31M | -73.59%12.96M | -13.26%196.26M | -59.04%39.08M |
Operating expense | 3.68%7.84M | 38.90%11.5M | 23.34%10.5M | 11.27%32.29M | -4.43%7.94M | 13.28%7.56M | 16.96%8.28M | 22.30%8.51M | -3.49%29.02M | 3.18%8.31M |
Selling and administrative expenses | 3.74%6.83M | -8.84%6.32M | -1.11%7.66M | 9.96%28.27M | -5.06%7M | 11.40%6.59M | 8.65%6.93M | 28.25%7.75M | 5.13%25.71M | 7.84%7.37M |
-General and administrative expense | 3.74%6.83M | -8.84%6.32M | -1.11%7.66M | 9.96%28.27M | -5.06%7M | 11.40%6.59M | 8.65%6.93M | 28.25%7.75M | 5.13%25.71M | 7.84%7.37M |
Other operating expenses | 3.29%1.01M | 284.28%5.18M | 272.05%2.84M | 21.48%4.02M | 0.54%937K | 27.86%973K | 92.71%1.35M | -16.90%762K | -41.02%3.31M | -23.10%932K |
Operating profit | 1,012.04%20.53M | 43.87%18.74M | 419.27%23.07M | -78.55%35.87M | -32.88%20.65M | -104.98%-2.25M | -73.52%13.03M | -89.44%4.44M | -14.76%167.24M | -64.78%30.77M |
Net non-operating interest income expense | -57.41%-2.22M | -69.52%-2.73M | -155.44%-3.22M | 24.08%-6.11M | -21.65%-1.83M | 28.88%-1.41M | 31.07%-1.61M | 43.42%-1.26M | 47.04%-8.05M | 37.04%-1.51M |
Non-operating interest income | 27.38%749K | 38.65%721K | 7.01%824K | 155.95%2.67M | 18.80%790K | 101.37%588K | 664.71%520K | 4,429.41%770K | 576.62%1.04M | 6,550.00%665K |
Non-operating interest expense | 48.57%2.97M | 61.99%3.45M | 99.11%4.04M | -3.45%8.78M | 20.77%2.62M | -12.17%2M | -11.39%2.13M | -9.50%2.03M | -40.78%9.09M | -9.62%2.17M |
Other net income (expense) | 111.58%3.27M | 5,885.60%7.48M | -181.48%-912K | -23,760.11%-42.12M | -3,024.15%-13.72M | -1,214.17%-28.2M | -83.70%125K | -116.22%-324K | -83.16%178K | -107.42%-439K |
Special income (charges) | 112.47%3.5M | --7.57M | ---978K | ---41.72M | ---13.62M | ---28.1M | --0 | --0 | --0 | --0 |
-Less:Impairment of capital assets | -96.58%961K | --5.63M | ---- | --41.72M | --13.62M | --28.1M | --0 | ---- | --0 | --0 |
-Gain on sale of property,plant,equipment | --4.47M | --13.21M | ---978K | --0 | --0 | --0 | --0 | --0 | --0 | ---- |
Other non- operating income (expenses) | -139.00%-239K | -172.00%-90K | 120.37%66K | -322.47%-396K | 77.68%-98K | 95.34%-100K | -83.70%125K | -116.22%-324K | -67.10%178K | -534.65%-439K |
Income before tax | 167.71%21.57M | 103.56%23.49M | 562.34%18.94M | -107.75%-12.36M | -82.28%5.11M | -177.63%-31.86M | -75.77%11.54M | -93.17%2.86M | -12.46%159.36M | -68.29%28.83M |
Income tax | ||||||||||
Net income | 167.71%21.57M | 103.56%23.49M | 562.34%18.94M | -107.75%-12.36M | -82.28%5.11M | -177.63%-31.86M | -75.77%11.54M | -93.17%2.86M | -12.46%159.36M | -68.29%28.83M |
Net income continuous Operations | 167.71%21.57M | 103.56%23.49M | 562.34%18.94M | -107.75%-12.36M | -82.28%5.11M | -177.63%-31.86M | -75.77%11.54M | -93.17%2.86M | -12.46%159.36M | -68.29%28.83M |
Minority interest income | -17.86%115K | 223.81%26K | -35.84%145K | -34.77%514K | 13.42%169K | -36.36%140K | -108.64%-21K | 28.41%226K | 1,973.68%788K | 292.11%149K |
Net income attributable to the parent company | 167.05%21.46M | 102.97%23.47M | 613.67%18.8M | -108.12%-12.87M | -82.78%4.94M | -178.39%-32M | -75.60%11.56M | -93.68%2.63M | -12.87%158.58M | -68.44%28.68M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 167.05%21.46M | 102.97%23.47M | 613.67%18.8M | -108.12%-12.87M | -82.78%4.94M | -178.39%-32M | -75.60%11.56M | -93.68%2.63M | -12.87%158.58M | -68.44%28.68M |
Basic earnings per share | 166.67%0.5 | 100.00%0.54 | 633.33%0.44 | -108.02%-0.3 | -82.09%0.12 | -178.13%-0.75 | -75.89%0.27 | -93.94%0.06 | -13.63%3.74 | -68.98%0.67 |
Diluted earnings per share | 165.33%0.49 | 100.00%0.54 | 616.67%0.43 | -108.11%-0.3 | -83.58%0.11 | -178.95%-0.75 | -75.45%0.27 | -93.81%0.06 | -13.35%3.7 | -68.54%0.67 |
Dividend per share | 126.67%0.34 | 180.00%0.42 | -18.00%0.41 | -65.33%0.95 | -80.77%0.15 | -70.00%0.15 | -81.01%0.15 | -25.37%0.5 | 756.25%2.74 | 420.00%0.78 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |